General Clinical Research Center is categorized under Medical Labs in Chapel Hill, NC and active since 2002.
General Clinical Research Center was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Mary Paine at the company’s single location by writing to 7600 Unc Hosp Cb Room 3018, Chapel Hill, North Carolina NC 27599 or by phoning (919) 966-6022. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | General Clinical Research Center |
| Contact Person: | Mary Paine |
| Address: | 7600 Unc Hosp Cb Room 3018, Chapel Hill, North Carolina 27599 |
| Phone Number: | (919) 966-6022 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
General Clinical Research Center was started in 2002 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mary Paine for inquiries that concern General Clinical Research Center by calling the company number (919) 966-6022, as your correspondence is most welcome. Additionally, the physical location of the single location of General Clinical Research Center can be found at the coordinates 35.91116,-79.06107 as well as the street address 7600 Unc Hosp Cb Room 3018 in Chapel Hill, North Carolina 27599.
For its online presence, you may visit General Clinical Research Center’s website at and engage with its social media outlets through on Twitter and on Facebook.